Design, synthesis and activity screening of cedrol derivatives as small molecule JAK3 inhibitors

被引:0
作者
Ma, Bingjing [2 ]
Li, Hua [2 ]
Huang, Yuan [3 ]
Guo, Yaming [1 ]
Xu, Caizhu [1 ]
Li, Wei [1 ]
机构
[1] Shenyang Pharmaceut Univ, Dept Funct Food & Wine, Shenyang 110016, Peoples R China
[2] Shenyang Pharmaceut Univ, Dept Tradit Chinese Mat Med, Shenyang 110016, Peoples R China
[3] Liaoning Inspect Examinat & Certificat Ctr, Shenyang 110170, Peoples R China
关键词
JAK3; inhibitor; Cedrol; Structural modification; Activity screening; DISCOVERY;
D O I
10.1016/j.bioorg.2024.107762
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The JAK-STAT signalling pathway is considered to be a significant role involved in the regulation of inflammatory diseases and immune responses, which indicate that specific inhibition of JAK-STAT pathway would be a potential key strategy for RA (Rheumatoid arthritis) treatment. Cedrol (CE), found from ginger by our group earlier, has been proven to play an excellent role in ameliorating RA via acting on JAK3. In this study, 27 new (1, 3-28), along with one known (2) derivatives of CE were synthesized by using chloroacetic acid and acryloyl chloride as intermediate ligands. In vitro, the inhibition effect on JAK kinases were performed using HTRF (Homogenous Time-Resolved Fluorescence) detection technology, which is more convenient and stable than traditional methods. The results compared with the secretion of LPS-induced p-JAK3 can better reflect the true kinase-selective effect of the compounds. Compound 22 was identified as a potent inhibitor to reduce the secretion of LPS-induced p-JAK3 with a dose-dependent manner. Given these results, compound 22 could serve as a favourable inhibitor of JAK3 for further research.
引用
收藏
页数:16
相关论文
共 30 条
[1]   Diagnosis and Management of Rheumatoid Arthritis A Review [J].
Aletaha, Daniel ;
Smolen, Josef S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (13) :1360-1372
[3]   Immunosuppressive Effects of Natural α,β-Unsaturated Carbonyl-Based Compounds, and Their Analogs and Derivatives, on Immune Cells: A Review [J].
Arshad, Laiba ;
Jantan, Ibrahim ;
Bukhari, Syed Nasir Abbas ;
Haque, Md. Areeful .
FRONTIERS IN PHARMACOLOGY, 2017, 8
[4]   JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects [J].
Banerjee, Shubhasree ;
Biehl, Ann ;
Gadina, Massimo ;
Hasni, Sarfaraz ;
Schwartz, Daniella M. .
DRUGS, 2017, 77 (05) :521-546
[5]   Inborn Errors of Human JAKs and STATs [J].
Casanova, Jean-Laurent ;
Holland, Steven M. ;
Notarangelo, Luigi D. .
IMMUNITY, 2012, 36 (04) :515-528
[6]   Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases [J].
Clark, James D. ;
Flanagan, Mark E. ;
Telliez, Jean-Baptiste .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (12) :5023-5038
[7]   SPONDYLOARTHRITIS Selective JAK inhibition for AS [J].
Collison, Joanna .
NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (12) :686-686
[8]   Rheumatoid Arthritis Early Diagnosis and Treatment [J].
Cush, John J. .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2022, 48 (02) :537-547
[9]   Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis [J].
Elemam, Noha Mousaad ;
Hannawi, Suad ;
Maghazachi, Azzam A. .
IMMUNOTARGETS AND THERAPY, 2020, 9 :43-56
[10]   JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis [J].
Fragoulis, George E. ;
McInnes, Iain B. ;
Siebert, Stefan .
RHEUMATOLOGY, 2019, 58 :43-54